Medical Device Network on MSN
Cleveland Diagnostics’ IsoPSA secures FDA approval for prostate cancer
The decision is supported by evidence from a clinical study and data from supporting analytical validation trials.
Local anesthetic transperineal (LATP) biopsy for prostate cancer detection is gaining in popularity due to concerns about infectious complications with transrectal ultrasound (TRUS) biopsy. LATP ...
MedPage Today on MSN
FDA OKs Blood-Based Test to Help Detect High-Grade Prostate Tumors
IsoPSA can provide more information for biopsy decisions ...
Research into magnetic resonance imaging (MRI) for prostate cancer screening and diagnosis has been ongoing for more than a decade. Initially, MRI was thought to be important for achieving two goals.
Micro-ultrasound–guided biopsies were found for the first time to be “noninferior” to MRI-guided procedures, according to new research presented at the 2025 annual congress of the European Association ...
A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators showed that a newer technique for collecting prostate biopsy samples reduced the risk of ...
Dr. Neal Patel says biopsy results may not fully capture prostate cancer risk, stressing that PSA, stage and disease volume should also guide treatment. Biopsy results alone may not fully capture the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback